Cell Membrane-Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme.
Apoptosis
Blood-Brain Barrier
/ pathology
Cell Line, Tumor
Cell Membrane
/ metabolism
Drug Liberation
Dynamic Light Scattering
Endocytosis
Fluorescence
Glioblastoma
/ diagnosis
Humans
Hyperthermia, Induced
Magnetite Nanoparticles
/ chemistry
Oxygen
/ metabolism
Protein Corona
Reactive Oxygen Species
/ metabolism
Temperature
Theranostic Nanomedicine
cell membrane-coated nanocubes
glioblastoma
homotypic targeting
magnetic hyperthermia
theranostics
Journal
Advanced healthcare materials
ISSN: 2192-2659
Titre abrégé: Adv Healthc Mater
Pays: Germany
ID NLM: 101581613
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
15
05
2019
revised:
15
07
2019
pubmed:
8
8
2019
medline:
28
8
2020
entrez:
8
8
2019
Statut:
ppublish
Résumé
In this study, hybrid nanocubes composed of magnetite (Fe
Identifiants
pubmed: 31389193
doi: 10.1002/adhm.201900612
pmc: PMC6754263
mid: EMS83997
doi:
Substances chimiques
Magnetite Nanoparticles
0
Protein Corona
0
Reactive Oxygen Species
0
Oxygen
S88TT14065
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1900612Subventions
Organisme : European Research Council
ID : 709613
Pays : International
Organisme : COST Action MyWAVE
ID : CA17115
Pays : International
Organisme : COST Action EURELAX
ID : CA15209
Pays : International
Informations de copyright
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Références
Drug Resist Updat. 2011 Jun;14(3):191-201
pubmed: 21466972
ACS Biomater Sci Eng. 2019 Feb 11;5(2):670-682
pubmed: 33405830
J Control Release. 2018 Jan 28;270:120-134
pubmed: 29203413
Nanomedicine (Lond). 2019 Mar;14(6):727-752
pubmed: 30574827
Science. 2016 Apr 8;352(6282):175-80
pubmed: 27124451
MethodsX. 2018 Jun 18;5:648-651
pubmed: 29998067
Nat Methods. 2014 Mar;11(3):319-24
pubmed: 24487582
Biomed Res Int. 2015;2015:320941
pubmed: 25866775
Nat Protoc. 2009;4(3):309-24
pubmed: 19214182
Nano Today. 2015 Aug;10(4):487-510
pubmed: 26640510
Ageing Res Rev. 2013 Jan;12(1):376-90
pubmed: 23123177
Nano Lett. 2016 Sep 14;16(9):5895-901
pubmed: 27513184
Hypoxia (Auckl). 2015 Dec 11;3:83-92
pubmed: 27774485
Small. 2016 Aug;12(30):4056-62
pubmed: 27337109
Sci Rep. 2014 Oct 21;4:6701
pubmed: 25330751
J Control Release. 2016 Aug 10;235:34-47
pubmed: 27208862
Redox Biol. 2015 Dec;6:174-182
pubmed: 26233703
Nanomedicine. 2018 Oct;14(7):2397-2405
pubmed: 28552642
ACS Nano. 2017 Mar 28;11(3):2494-2508
pubmed: 28107625
Int J Mol Sci. 2018 Nov 21;19(11):
pubmed: 30469352
Colloids Surf B Biointerfaces. 2016 Dec 1;148:95-103
pubmed: 27591575
Adv Mater. 2018 Feb;30(6):
pubmed: 29266514
Mater Today (Kidlington). 2011 Jul;14(7-8):330-338
pubmed: 22389583
J Neurooncol. 2018 Jan;136(1):79-86
pubmed: 28988377
Neurosurgery. 2017 Sep 1;64(CN_suppl_1):165-176
pubmed: 28899059
Cureus. 2017 Jun 26;9(6):e1396
pubmed: 28845375
IEEE Trans Biomed Eng. 1984 Jan;31(1):70-5
pubmed: 6724612
J Neurooncol. 2011 Jan;101(1):57-66
pubmed: 20443129
Nanoscale. 2018 Dec 20;11(1):72-88
pubmed: 30357214
Free Radic Res. 2010 May;44(5):479-96
pubmed: 20370557
Nano Lett. 2013 Jun 12;13(6):2399-406
pubmed: 23659603
Cancer Res. 2015 Mar 15;75(6):1113-22
pubmed: 25634210
PLoS One. 2017 Feb 27;12(2):e0172791
pubmed: 28241049
Chemother Res Pract. 2012;2012:192362
pubmed: 22400111
ACS Nano. 2018 Jun 26;12(6):5241-5252
pubmed: 29800517
Front Bioeng Biotechnol. 2017 Dec 18;5:80
pubmed: 29326928
ACS Nano. 2014 Apr 22;8(4):3202-12
pubmed: 24702320
Colloids Surf B Biointerfaces. 2017 Nov 1;159:30-38
pubmed: 28779638
ACS Nano. 2016 Jan 26;10(1):633-647
pubmed: 26650065
Mol Cell Proteomics. 2002 Dec;1(12):947-55
pubmed: 12543931
J Immunol. 2000 Jun 1;164(11):6075-81
pubmed: 10820293